|
|
The Role of IL-II in the development of autoimmune response in multiple sclerosis |
| 5R01AI131238-03 |
MARKOVIC-PLESE, SILVA |
NIAID |
2020 |
|
|
Regulation of TH17 plasticity and stemness by mTORC1 |
| 5R01AI131703-03 |
CHI, HONGBO |
NIAID |
2020 |
|
|
Tolerogenic dual microparticle system for treatment of multiple sclerosis |
| 5R01AI133623-04 |
KESELOWSKY, BENJAMIN GEORGE |
NIAID |
2020 |
|
|
Regulation of encephalitogenic T cells by CRAC channels |
| 5R01AI137004-03 |
FESKE, STEFAN |
NIAID |
2020 |
|
|
Understanding the roles type I Interferon and TH17 play in Neuromyelitis Optica and other autoimmune diseases. |
| 5R01AI137047-03 |
AXTELL, ROBERT C |
NIAID |
2020 |
|
|
Linking diet, gut microbiota and autoimmune disease: Bacteria induced phytoestrogen metabolites impact immune function in Experimental Autoimmune Encephalitis |
| 5R01AI137075-03 |
MANGALAM, ASHUTOSH KUMAR |
NIAID |
2020 |
|
|
Targeted depletion of programmed death-1 positive cells, a method that not only stops autoimmune attack but also preserves adaptive immunity |
| 5R01AI139535-02 |
CHEN, MINGNAN |
NIAID |
2020 |
|
|
Defining the Role of Molecules Unique to Encephalitogenic T Cells in MS |
| 5R01AI140741-02 |
LOVETT-RACKE, AMY E |
NIAID |
2020 |
|
|
Statistical methods for characterizing patients who highly-benefit from treatments and programs in Alzheimers, HIV, and other heterogeneous diseases |
| 5R01AI140854-03 |
FRANGAKIS, CONSTANTINE E |
NIAID |
2020 |
|
|
The Role of Schwann Cell Lipid Droplets In Neuropathology of Leprosy |
| 5R01AI141526-02 |
BELISLE, JOHN T |
NIAID |
2020 |
